MedElevator Войти в исследования
← Поиск публикаций

DOI 10.36401/jipo-23-47

Медицинская библиотека · Journal of immunotherapy and precision oncology · 2024

Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma.

Deshpande Anagha, Munoz Javier, Kurzrock Razelle

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

A 62-year-old man presented with a slowly growing, painless lesion on his face. This eventually led to a progressive left-eye vision lesion, and the patient was subsequently diagnosed with advanced basal cell carcinoma (BCC). Of note, BCC involving cranial nerves is extremely rare, making this case unique and important to highlight. Standard treatment options for BCC involve surgery, radiation, or platinum-based chemotherapy. However, targeted therapies such as sonidegib and vismodegib - sonic hedgehog pathway inhibitors - have emerged that have been approved for treating BCC, as have anti-PD1 immunotherapies, such as cemiplimab, with their success likely based on the high tumor mutational burden seen in some of these tumors. Epidermal growth factor receptor (EGFR) inhibitors also serve a role in treating this condition as well. Molecular studies on metastatic/advanced BCC and other rare malignancies may inform treatment therapeutic decisions.

Для цитирования: Deshpande Anagha, Munoz Javier, Kurzrock Razelle. Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma.. Journal of immunotherapy and precision oncology. 2024. DOI: 10.36401/jipo-23-47.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.